PURPOSE: Little is known about why women with breast cancer who have surgery do not receive proven effective postsurgical adjuvant treatments. METHODS: We surveyed 258 women who recently underwent surgical treatment at six New York City hospitals for early-stage breast cancer about their care, knowledge, and beliefs about breast cancer and its treatment. As per national guidelines, all women should have received adjuvant treatment. Adjuvant treatment data were obtained from inpatient and outpatient charts. Factor analysis was used to create scales scored to 100 of treatment beliefs and knowledge, medical mistrust, and physician communication about treatment. Bivariate and multivariate analyses assessed differences between treated and untreated women. RESULTS: Compared with treated women, untreated women were less likely to know that adjuvant therapies increase survival (on a 100-point scale; 66 v 75; P < .0001), had greater mistrust (64 v 53; P = .001), and had less self-efficacy (92 v 97; P < .05); physician communication about treatment did not affect patient knowledge of treatment benefits (r = 0.8; P = .21). Multivariate analysis found that untreated women were more likely to be 70 years or older (adjusted relative risk [aRR], 1.11; 95% CI, 1.00 to 1.13), to have comorbidities (aRR, 1.10; 95% CI, 1.04 to 1.12), and to express mistrust in the medical delivery system (aRR, 1.003; 95% CI, 1.00 to 1.007), even though they were more likely to believe adjuvant treatments were beneficial (aRR, 0.99; 95% CI, 0.98 to 0.99; model c, 0.84; P < or = .0001). CONCLUSION: Patient knowledge and beliefs about treatment and medical mistrust are mutable factors associated with underuse of effective adjuvant therapies. Physicians may improve cancer care by ensuring that discussions about adjuvant therapy include a clear presentation of the benefits, not just the risks of treatment, and by addressing patient trust in and concerns about the medical system.
PURPOSE: Little is known about why women with breast cancer who have surgery do not receive proven effective postsurgical adjuvant treatments. METHODS: We surveyed 258 women who recently underwent surgical treatment at six New York City hospitals for early-stage breast cancer about their care, knowledge, and beliefs about breast cancer and its treatment. As per national guidelines, all women should have received adjuvant treatment. Adjuvant treatment data were obtained from inpatient and outpatient charts. Factor analysis was used to create scales scored to 100 of treatment beliefs and knowledge, medical mistrust, and physician communication about treatment. Bivariate and multivariate analyses assessed differences between treated and untreated women. RESULTS: Compared with treated women, untreated women were less likely to know that adjuvant therapies increase survival (on a 100-point scale; 66 v 75; P < .0001), had greater mistrust (64 v 53; P = .001), and had less self-efficacy (92 v 97; P < .05); physician communication about treatment did not affect patient knowledge of treatment benefits (r = 0.8; P = .21). Multivariate analysis found that untreated women were more likely to be 70 years or older (adjusted relative risk [aRR], 1.11; 95% CI, 1.00 to 1.13), to have comorbidities (aRR, 1.10; 95% CI, 1.04 to 1.12), and to express mistrust in the medical delivery system (aRR, 1.003; 95% CI, 1.00 to 1.007), even though they were more likely to believe adjuvant treatments were beneficial (aRR, 0.99; 95% CI, 0.98 to 0.99; model c, 0.84; P < or = .0001). CONCLUSION:Patient knowledge and beliefs about treatment and medical mistrust are mutable factors associated with underuse of effective adjuvant therapies. Physicians may improve cancer care by ensuring that discussions about adjuvant therapy include a clear presentation of the benefits, not just the risks of treatment, and by addressing patient trust in and concerns about the medical system.
Authors: Sjaak Molenaar; Mirjam Sprangers; Frans Oort; Emiel Rutgers; Ernest Luiten; Jan Mulder; Marjolijn van Meeteren; Hanneke de Haes Journal: Patient Educ Couns Date: 2006-09-01
Authors: Bret R Shaw; Jeong Yeob Han; Timothy Baker; Jeffre Witherly; Robert P Hawkins; Fiona McTavish; David H Gustafson Journal: Health Educ Res Date: 2006-07-07
Authors: Shelley M Enger; Soe Soe Thwin; Diana S M Buist; Terry Field; Floyd Frost; Ann M Geiger; Timothy L Lash; Marianne Prout; Marianne Ulcickas Yood; Feifei Wei; Rebecca A Silliman Journal: J Clin Oncol Date: 2006-09-20 Impact factor: 44.544
Authors: Angela Fagerlin; Indu Lakhani; Paula M Lantz; Nancy K Janz; Monica Morrow; Kendra Schwartz; Dennis Deapen; Barbara Salem; Lihua Liu; Steven J Katz Journal: Patient Educ Couns Date: 2006-07-24
Authors: Sue P Heiney; Linda J Hazlett; Sally P Weinrich; Linda M Wells; Swann Arp Adams; Sandra Millon Underwood; Rudolph S Parrish Journal: Res Theory Nurs Pract Date: 2011 Impact factor: 0.688
Authors: Pelagia G Tsoutsou; Yazid Belkacemi; Joseph Gligorov; Abraham Kuten; Hamouda Boussen; Nuran Bese; Michael I Koukourakis Journal: Oncologist Date: 2010-11-01
Authors: Amanda R Sergesketter; Samantha M Thomas; Whitney O Lane; Jonah P Orr; Ronnie L Shammas; Oluwadamilola M Fayanju; Rachel A Greenup; Scott T Hollenbeck Journal: Plast Reconstr Surg Date: 2019-06 Impact factor: 4.730
Authors: Nina A Bickell; Andrea N Geduld; Kathie-Ann Joseph; Joseph A Sparano; M Margaret Kemeny; Soji Oluwole; Tehillah Menes; Anitha Srinivasan; Rebeca Franco; Kezhen Fei; Howard Leventhal Journal: J Oncol Pract Date: 2013-09-10 Impact factor: 3.840
Authors: Caroline M Johnson; Yamile Molina; Magaly Blas; Mallory Erickson; Angela Bayer; Marina Chiappe Gutierrez; Paul E Nevin; Isaac Alva; Deepa Rao Journal: Health Care Women Int Date: 2018-02-02
Authors: Gery P Guy; Joseph Lipscomb; Theresa W Gillespie; Michael Goodman; Lisa C Richardson; Kevin C Ward Journal: Health Serv Res Date: 2014-12-10 Impact factor: 3.402
Authors: Jennifer L Beebe-Dimmer; Terrance L Albrecht; Tara E Baird; Julie J Ruterbusch; Theresa Hastert; Felicity W K Harper; Michael S Simon; Judith Abrams; Kendra L Schwartz; Ann G Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-11-27 Impact factor: 4.254
Authors: Katrina Armstrong; Mary Putt; Chanita H Halbert; David Grande; Jerome Sanford Schwartz; Kaijun Liao; Noora Marcus; Mirar B Demeter; Judy A Shea Journal: Med Care Date: 2013-02 Impact factor: 2.983